AYTU — AYTU BIOPHARMA, INC
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2017-10-20.
Performance
Technicals
Others in Healthcare
Measured signals that fired on AYTU
| date | signal | measured base rate |
|---|---|---|
| 2026-03-18 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-28 | Selhorn Ryan J Chief Financial Officer | Grant or award | 25.0K | 0.00 | 0 |
| 2026-07-28 | JAIN ABHINAV Director | Grant or award | 10.0K | 0.00 | 0 |
| 2026-07-28 | DOCKERY CARL Director | Grant or award | 10.0K | 0.00 | 0 |
| 2026-07-28 | Donofrio John Jr. Director | Grant or award | 10.0K | 0.00 | 0 |
| 2026-07-28 | Disbrow Jarrett Chief Business Officer | Grant or award | 15.0K | 0.00 | 0 |
| 2026-07-28 | PYSZCZYMUKA GREG Chief Commercial Officer | Grant or award | 20.0K | 0.00 | 0 |
| 2026-07-28 | Disbrow Joshua R. Chief Executive Officer | Grant or award | 30.0K | 0.00 | 0 |
| 2026-07-28 | LIU VIVIAN H Director | Grant or award | 10.0K | 0.00 | 0 |
| 2025-10-03 | Disbrow Jarrett Chief Business Officer | Grant or award | 12.5K | 0.00 | 0 |
| 2025-10-03 | Disbrow Jarrett Chief Business Officer | Grant or award | 19.6K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Nantahala Capital Management, LLC | 3.0M | 1.1M |
| Stonepine Capital Management, LLC | 2.2M | 792.3K |
| AWM Investment Company, Inc. | 1.7M | 619.6K |
| DIADEMA PARTNERS LP | 963.9K | 353.1K |
| VANGUARD CAPITAL MANAGEMENT LLC | 712.9K | 261.1K |
| TWO SIGMA INVESTMENTS, LP | 333.0K | 122.0K |
| RENAISSANCE TECHNOLOGIES LLC | 255.9K | 93.7K |
| Persistent Asset Partners Ltd | 253.6K | 92.9K |
| GEODE CAPITAL MANAGEMENT, LLC | 252.9K | 92.6K |
| VANGUARD FIDUCIARY TRUST CO | 128.4K | 47.0K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-14 | — | on EDGAR ↗ |
| 4 | 2026-07-30 | 2026-07-28 | on EDGAR ↗ |
| 4 | 2026-07-30 | 2026-07-28 | on EDGAR ↗ |
| 4 | 2026-07-30 | 2026-07-28 | on EDGAR ↗ |
| 4 | 2026-07-30 | 2026-07-28 | on EDGAR ↗ |
| 4 | 2026-07-30 | 2026-07-28 | on EDGAR ↗ |
| 4 | 2026-07-30 | 2026-07-28 | on EDGAR ↗ |
| 4 | 2026-07-30 | 2026-07-28 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Ask the AI about AYTU
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →